Selected stem cell populations in pediatric acute lymphoblastic leukemia

Area of Science:

• Hematology
• Stem Cell Biology
• Pediatric Oncology

Background:

• Acute lymphoblastic leukemia (ALL) involves abnormal hematopoietic stem cell (HSC) maturation, leading to malignant clones.
• Disease relapse in ALL can stem from incomplete eradication or clone evolution.
• The role of stem cells, specifically very small embryonic-like stem cells (VSELs) and HSCs, in ALL pathogenesis and treatment response requires further elucidation.

Purpose of the Study:

• To investigate the dynamic changes in VSELs and HSCs during the induction phase of pediatric ALL treatment.
• To determine the correlation between VSEL and HSC levels and ALL diagnosis, disease progression, and treatment outcomes.

Main Methods:

• A retrospective study analyzed peripheral blood and bone marrow samples from 60 pediatric ALL patients and 48 healthy controls.
• Flow cytometry was employed to assess VSEL and HSC populations at four distinct time points.
• Data were analyzed to correlate stem cell levels with clinical parameters, including bone marrow blasts and minimal residual disease (MRD).

Main Results:

• Both VSELs and HSCs were elevated at ALL diagnosis compared to controls, declining significantly by day 15.
• HSCs increased while VSELs decreased from day 15 to week 12.
• Higher initial HSCs correlated with increased bone marrow blasts; lower VSELs or HSCs at diagnosis suggested improved treatment response. Lower VSELs at diagnosis predicted lower day 15 MRD levels.

Conclusions:

• HSCs and VSELs play significant roles in pediatric ALL, potentially contributing to the neoplastic process.
• These stem cell populations demonstrate prognostic value for predicting initial treatment outcomes in pediatric ALL.
• Monitoring VSEL and HSC dynamics may aid in risk stratification and personalized treatment strategies for ALL.